Literature DB >> 30588552

Clinical features of hypertrophic pachymeningitis in a center survey.

Gonçalo Cação1, Margarida Calejo1, José Eduardo Alves2, Pedro Bettencourt Medeiros3, Nuno Vila-Cha1, Teresa Mendonça3, Ricardo Taipa4, Ana Martins Silva1, Joana Damásio5.   

Abstract

BACKGROUND: Hypertrophic pachymeningitis (HP) is characterized by cranial and/or spinal thickening of the dura mater with or without associated inflammation. Neuroimaging studies reveal dura mater thickening and focal or diffuse contrast enhancement. It is described in association with trauma, infections, tumors, autoimmune/inflammatory diseases, and cerebrospinal fluid hypotension syndrome, with some cases remaining idiopathic.
METHODS: A retrospective study was conducted with patients' identification through a key terms search within MRI reports in the period of July 2008 to September 2015. Clinical files, MRI, laboratory, and pathology data were reviewed.
RESULTS: Fifty-three patients were identified and 20 were excluded because they did not meet the inclusion criteria. Of the 33 included, 19 were female, with a mean age at symptoms onset of 51.2 ± 17.6 years. The most common presenting symptoms were headache and cranial nerves palsy, followed by seizures, delirium, lumbar pain, cognitive decline, motor deficit, and language impairment. In 17 patients, a neoplastic etiology was identified; in eight, inflammatory/autoimmune; in six, infectious; and two were classified as idiopathic. Of the eight patients with inflammatory/autoimmune etiology, four had possible IgG4-related disease (IgG4-RD) and the remaining had granulomatosis with polyangiitis, sarcoidosis, rheumatoid arthritis, and Tolosa-Hunt syndrome. Treatment was directed according to the underlying etiology. DISCUSSION: In the described series, a female predominance was identified, with symptoms' onset in the 5th decade. Although headache was the most common symptom, clinical presentation was varied, emphasizing the role of MRI in HP diagnosis. The underlying etiologies were diverse, with only a few cases remaining idiopathic, also reflecting the contribution of the recently described IgG4-RD.

Entities:  

Keywords:  Hypertrophic pachymeningitis; IgG4-related disease; Magnetic resonance imaging; Neurological symptoms

Mesh:

Year:  2018        PMID: 30588552     DOI: 10.1007/s10072-018-3689-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  6 in total

Review 1.  Tolosa-Hunt Syndrome: A Review of Diagnostic Criteria and Unresolved Issues.

Authors:  Paromita Dutta; Kamlesh Anand
Journal:  J Curr Ophthalmol       Date:  2021-07-05

2.  Rapid bilateral visual loss as the initial clinical manifestation in idiopathic hypertrophic cranial pachymeningitis.

Authors:  Weiyang Shao; Chunyu Tian; Lixiong Gao; Bei Cui; Qian Shi
Journal:  Clin Case Rep       Date:  2022-05-06

3.  Idiopathic hypertrophic pachymeningitis with anticardiolipin antibody: A case report.

Authors:  Chi-Shun Wu; Hung-Ping Wang; Sheng-Feng Sung
Journal:  Medicine (Baltimore)       Date:  2021-01-15       Impact factor: 1.817

4.  Hypertrophic Pachymeningitis in a Southern Chinese Population: A Retrospective Study.

Authors:  Xuewen Xiao; Dongni Fu; Li Feng
Journal:  Front Neurol       Date:  2020-11-17       Impact factor: 4.003

5.  IgG4-related hypertrophic pachymeningitis with ANCA-positivity: A case series report and literature review.

Authors:  Cheng Xia; Ping Li
Journal:  Front Neurol       Date:  2022-09-15       Impact factor: 4.086

6.  IgG4-related hypertrophic pachymeningitis with tumor-like intracranial and intracerebral lesions.

Authors:  Majid Esmaeilzadeh; Mete Dadak; Oday Atallah; Nora Möhn; Thomas Skripuletz; Christian Hartmann; Rozbeh Banan; Joachim K Krauss
Journal:  Acta Neurochir (Wien)       Date:  2022-08-17       Impact factor: 2.816

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.